Chargement en cours...
The neuroprotective agent Rasagiline mesylate attenuates cardiac remodeling after experimental myocardial infarction
AIM: Rasagiline mesylate (N‐propargyl‐1 (R)‐aminoindan) (RG) is a selective, potent irreversible inhibitor of monoamine oxidase‐B with cardioprotective and anti‐apoptotic properties. We investigated whether it could be cardioprotective in a rat model undergoing experimental myocardial infarction (MI...
Enregistré dans:
Publié dans: | ESC Heart Fail |
---|---|
Auteurs principaux: | , , , , , , , |
Format: | Artigo |
Langue: | Inglês |
Publié: |
John Wiley and Sons Inc.
2017
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5542732/ https://ncbi.nlm.nih.gov/pubmed/28772050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12140 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|